Randal W. Scott, Director at BridgeBio Pharma, Inc. (BBIO), sold 20,000 shares at $66.25 ($1.3M) on 2025-11-17, disclosed to the SEC on 2025-11-19.
Scheduled sale ($1.3M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $66.25 | 3,801 | $252K | 18.9% |
| 2 | $66.25 | 3,801 | $252K | 18.9% |
| 3 | $66.89 | 6,199 | $415K | 31.1% |
| 4 | $66.89 | 6,199 | $415K | 31.1% |
| Total | $66.65 avg | 20,000 | $1.3M | 100% |
| Filing → |
| BBIO | SELL | 2024-06-05 | $76K | — | Filing → |
| BBIO | SELL | 2024-03-05 | $85K | — | Filing → |
| BBIO | SELL | 2023-12-20 | $80K | — | Filing → |